.August 28, 2024 07:00:01 AM

Analysts have been closely monitoring Stratasys Ltd. (NASDAQ: SSYS) as the consensus price target for the company has fluctuated over the past year. Despite challenges, Needham analyst James Ricchiuti set a price target of $12 for Stratasys, indicating a cautiously optimistic view on the company’s financial health and market position. Stratasys’ collaboration with CollPlant Biotechnologies on regenerative breast implants highlights its innovative capabilities and potential to tap into new market opportunities valued at $3.0 billion. These initiatives position Stratasys as a key player in the additive manufacturing industry, with a focus on sectors like healthcare and aerospace.